Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 6Genitourinary 5Gastrointestinal 5Sarcoma 3Breast 3Thoracic 2Head & Neck 2Gynecologic 2Endocrine 1Dermatologic 1

Conditions

Thoracic Diseases 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 463Cisplatin 379Paclitaxel 313Pemetrexed 300Docetaxel 242Erlotinib Hydrochloride 240Gemcitabine 232pembrolizumab 173Radiotherapy 172Bevacizumab 169Nivolumab 130Etoposide 106Gefitinib 95Vinorelbine 84durvalumab 71atezolizumab 68Cetuximab 65Topotecan 61Drug Therapy 57Ipilimumab 55Irinotecan 54osimertinib 53Radiosurgery 52Afatinib 51Surveys and Questionnaires 38130-nm albumin-bound paclitaxel 38Albumin-Bound Paclitaxel 37Taxes 35Cyclophosphamide 35Surgical Procedures, Operative 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Congresses as Topic × Thoracic × Clear all
NCT02133235 2015-11-23

The Need of Fiberoptic Bronchoscopy for Placing an Endobronchial Blocker

National Taiwan University Hospital

Phase NA Completed
112 enrolled 7 charts
Thoracic

Lung Neoplasms, Thoracic Diseases

NCT00005065 2013-06-04

Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 1 Completed
12 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡